中枢神经系统骨髓瘤:病变发生,诊断挑战和实际管理策略
Eirini Katodritou1, Evangelos Terpos2
1Department of Hematology Theagenio Cancer Hospital Thessaloniki Greece.
HemaSphere
|October 15, 2025
概括
中枢神经系统多发性骨髓瘤 (CNS-MM) 是一种罕见且具有攻击性的癌症. 本综述涉及中枢神经系统-MM的诊断和治疗挑战,为更好的患者管理提供了见解.
科学领域:
- 血液学 血液学 血液学
- 神经瘤学神经瘤学
- 在瘤学瘤学.
背景情况:
- 中枢神经系统多发性骨髓瘤 (CNS-MM) 是多发性骨髓瘤的一种罕见的外骨髓瘤表现.
- 它与预后不佳有关,并带来了重大治疗挑战.
- 关于其发病率,风险因素和最佳管理的数据有限.
研究的目的:
- 审查当前中枢神经系统-MM的诊断和治疗挑战.
- 为CNS-MM.提供对现实生活管理策略的实际见解.
主要方法:
- 关于中枢神经系统-MM.现有研究的文献综述.
- 对诊断标准和治疗方法的分析.
- 综合现实世界的管理数据.
主要成果:
- 中枢神经系统MM的诊断往往因其罕见性和非特异性症状而延迟.
- 治疗策略各不相同,通常是从系统性骨髓瘤协议中推断出来的.
- 长期结果仍然很差,突出了需要专门的方法.
结论:
- 改进的诊断工具和风险分层对于中枢神经系统MM至关重要.
- 多学科合作对于优化治疗和患者护理至关重要.
- 需要进一步的研究,以建立基于证据的指导方针,用于CNS-MM管理.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
7.2K
07:14Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
1.6K
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Multiple Sclerosis l: Introduction
19
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19
Myasthenia Gravis ll: Pathophysiology
49
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
Secondary Spinal Cord Injury llI: Pathophysiology
51
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
51
